ES2187963T3 - Sales farmaceuticamente aceptables de 3-sulfato de 3-hidroxi-estr-5(10)-en 17-ona activas con estrogenos. - Google Patents

Sales farmaceuticamente aceptables de 3-sulfato de 3-hidroxi-estr-5(10)-en 17-ona activas con estrogenos.

Info

Publication number
ES2187963T3
ES2187963T3 ES98918801T ES98918801T ES2187963T3 ES 2187963 T3 ES2187963 T3 ES 2187963T3 ES 98918801 T ES98918801 T ES 98918801T ES 98918801 T ES98918801 T ES 98918801T ES 2187963 T3 ES2187963 T3 ES 2187963T3
Authority
ES
Spain
Prior art keywords
hydroxy
pharmaceutically acceptable
sulfate
strogens
estr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98918801T
Other languages
English (en)
Inventor
Michael Z Kagan
Fangming Kong
Leonard Alexander Mcdonald
Panolil Raveendranath
Syed Muzafar Shah
Joseph Zeldis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Application granted granted Critical
Publication of ES2187963T3 publication Critical patent/ES2187963T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una sal farmacéuticamente aceptable de 3.beta-hidroxi-5(10)-estreno-17-ona 3-sulfato éster y una sal farmacéuticamente aceptable de 3.beta-hidroxi-5(10)-estreno-17-ona 3-sulfato éster, los cuales se utilizan como estrógenos.
ES98918801T 1997-05-02 1998-04-28 Sales farmaceuticamente aceptables de 3-sulfato de 3-hidroxi-estr-5(10)-en 17-ona activas con estrogenos. Expired - Lifetime ES2187963T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85056897A 1997-05-02 1997-05-02

Publications (1)

Publication Number Publication Date
ES2187963T3 true ES2187963T3 (es) 2003-06-16

Family

ID=25308509

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98918801T Expired - Lifetime ES2187963T3 (es) 1997-05-02 1998-04-28 Sales farmaceuticamente aceptables de 3-sulfato de 3-hidroxi-estr-5(10)-en 17-ona activas con estrogenos.

Country Status (14)

Country Link
EP (1) EP0980383B1 (es)
JP (1) JP2001523266A (es)
KR (1) KR20010012193A (es)
CN (1) CN1254341A (es)
AR (1) AR015375A1 (es)
AT (1) ATE230413T1 (es)
AU (1) AU730300B2 (es)
BR (1) BR9809437A (es)
CA (1) CA2289008A1 (es)
DE (1) DE69810461T2 (es)
DK (1) DK0980383T3 (es)
ES (1) ES2187963T3 (es)
WO (1) WO1998050413A1 (es)
ZA (1) ZA983698B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200301023A1 (ru) * 2001-03-16 2004-02-26 Уайт Заместительная терапия эстрогенами

Also Published As

Publication number Publication date
CN1254341A (zh) 2000-05-24
CA2289008A1 (en) 1998-11-12
JP2001523266A (ja) 2001-11-20
KR20010012193A (ko) 2001-02-15
DE69810461D1 (de) 2003-02-06
HK1025336A1 (en) 2000-11-10
AU7165598A (en) 1998-11-27
DE69810461T2 (de) 2003-10-02
WO1998050413A1 (en) 1998-11-12
DK0980383T3 (da) 2003-04-14
EP0980383A1 (en) 2000-02-23
ATE230413T1 (de) 2003-01-15
ZA983698B (en) 1999-11-01
EP0980383B1 (en) 2003-01-02
BR9809437A (pt) 2000-06-13
AR015375A1 (es) 2001-05-02
AU730300B2 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
ATE244015T1 (de) Formulierungen fuer faktor ix
MX9300298A (es) Conjugados de tioeter y procedimiento para su preparacion
RU2000106434A (ru) N-алканоилфенилаланиновые производные
DE69837924D1 (de) Chromophoren zur herstellung von neuen tandem-konjugaten
FI952033A7 (fi) Farmakologisesti aktiiviset pyrrolopyrimidiinijohdannaiset
DK1001813T3 (da) Farmaceutiske formuleringer indeholdende voriconazol
ES2176684T3 (es) Nuevas asociaciones de principios activos que contienen clopidogrel y un antitrombotico.
DE69433532D1 (de) Amphiphile imidazolinium-derivate
ES2148593T3 (es) Compuestos retinoides trienoicos novedosos y metodos.
FI933424A7 (fi) Peptidyyli-4-amino-2,2-difluori-3-okso-1,6-heksaanidinihappojohdannaiset tulehdusta vastustavina aineina
PT831826E (pt) Composicao farmaceutica que inclui um inibidor de proteinase e um monoglicerideo
AR012853A1 (es) Formulacion inyectable transparente de compuesto anestesico
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
SE9801494D0 (sv) Novel use
AR023699A1 (es) Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
NO980296L (no) Forbedrede terapeutiske midler
BG100248A (bg) Инхибитори на скваленсинтетаза
HRP20000400B1 (hr) Transmukozni pripravci levosimendana
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
FI922720A0 (fi) Farmakologiskt aktiva amidkarboxylatderivat.
AR026243A1 (es) Solucion oral de galantamina
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
TR199800068A3 (tr) Benzofenon türevlerinin hazirlanmasina yönelik metodlar.
PT837677E (pt) Derivados hexa-hidroxibifenilo bromados